Skip to main content
2024 Guide to Patient Support Services


2024 PSS Guide

AbbVie’s Vencompass

AbbVie offers the Vencompass program to support patients who have been prescribed Venclexta (Table).


This program is intended to provide product-related education and support to your patients taking Venclexta for an approved use during the ramp-up phase and throughout their therapy.

Venclexta nurses have experience in cancer care and are dedicated to:

  • Providing tools and resources to help your patients stay on track with their Venclexta treatment plan
  • Preparing your patients for upcoming appointments with you and your staff
  • Providing additional resources for patients to support them throughout their treatment
  • Providing resources to caregivers to help support their loved ones during their treatment.

For more information on the Vencompass program, please call 844-926-6727. Patients can enroll in Vencompass online.

Please note, financial assistance for Venclexta is provided for eligible patients through the Genentech Oncology Co-pay Assistance Program or the Genentech Patient Foundation.

TABLE AbbVie Oncology Drug

Patient support program

Venclexta (venetoclax)
Treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma; treatment, in combination with azacitidine, or decitabine, or low-dose cytarabine, of newly diagnosed acute myeloid leukemia in patients aged ≥75 years, or those who have comorbidities that preclude use of intensive induction chemotherapy
Patient support program